Delmeson en es it fr

Delmeson Brand names, Delmeson Analogs

Delmeson Brand Names Mixture

  • L-S 100 Soluble Powder (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Sulfate))
  • Lincomycin Spectinomycin 100 Soluble Powder (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Hydrochloride))
  • Lincomycin Spectinomycin 4.4% G Premix (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Hydrochloride))

Delmeson Chemical_Formula


Delmeson RX_link

Delmeson fda sheet

Delmeson FDA

Delmeson msds (material safety sheet)

Delmeson MSDS

Delmeson Synthesis Reference

No information avaliable

Delmeson Molecular Weight

376.462 g/mol

Delmeson Melting Point

297 oC

Delmeson H2O Solubility

30 mg/L

Delmeson State


Delmeson LogP


Delmeson Dosage Forms

Drops; Suspension

Delmeson Indication

A topical anti-inflammatory product for ophthalmic use. For the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe

Delmeson Pharmacology

No information avaliable

Delmeson Absorption

No information avaliable

Delmeson side effects and Toxicity

Side effects may include acute anterior uveitis and perforation of the globe. Keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperemia, loss of accommodation and ptosis have occasionally been reported following local use of corticosteroids. LD50 = 234 mg/kg (rats)

Delmeson Patient Information

Delmeson Organisms Affected

Humans and other mammals